In addition, we found that mRNA expression and protein synthesis of MMP-2, as well as wound healing and cell migration ability, were similar when we treated chondrosarcoma cells with visfatin 50 or 100 ng/mL, so we chose 50 ng/mL in all further experiments. The gene discussed is MMP2; the disease is chondrosarcoma.